Article
Hypertrophic cardiomyopathy-associated mutations drive stromal activation via EGFR-mediated paracrine signaling.
Science advances - 18 Oct 2024
Ewoldt Jourdan K, Wang Miranda C, McLellan Micheal A, Cloonan Paige E, Chopra Anant, Gorham Joshua, Li Linqing, DeLaughter Daniel M, Gao Xining, Lee Joshua H, Willcox Jon A L, Layton Olivia, Luu Rebeccah J, Toepfer Christopher N, Eyckmans Jeroen, Seidman Christine E, Seidman Jonathan G, Chen Christopher S
Abstract excerpt
Hypertrophic cardiomyopathy (HCM) is characterized by thickening of the left ventricular wall, diastolic dysfunction, and fibrosis, and is associated with mutations in genes encoding sarcomere proteins. While in vitro studies have used human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to study HCM, these models have not examined the multicellular interactions involved in fibrosis. Using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
